ESSEPNA
Google image searchProduct monograph
Active ingredients
alanine, 1.4 G/100 ML
arginine, 1.2 G/100 ML
glycine, 1.1 G/100 ML
histidine, 0.3 G/100 ML
isoleucine, 0.5 G/100 ML
leucine, 0.74 G/100 ML
lysine (l-lysine acetate), 0.66 G/100 ML
methionine, 0.43 G/100 ML
phenylalanine, 0.51 G/100 ML
proline, 1.12 G/100 ML
serine, 0.65 G/100 ML
taurine, 0.1 G/100 ML
threonine, 0.44 G/100 ML
tryptophan, 0.2 G/100 ML
tyrosine, 0.04 G/100 ML
valine, 0.62 G/100 ML
DIN: 02510324
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: FRESENIUS KABI CANADA LTD
Date: 25-JAN-2023
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BA — Solutions for parenteral nutrition (ATC, ATC/DDD)
- B05BA01 — AMINO ACIDS (ATC/DDD)
External Links for Essepna
Search on Google
- Essepna side effects
- Essepna dosage
- alanine side effects
- alanine dosage
- arginine side effects
- arginine dosage
- glycine side effects
- glycine dosage
- histidine side effects
- histidine dosage
- isoleucine side effects
- isoleucine dosage
- leucine side effects
- leucine dosage
- lysine side effects
- lysine dosage
- methionine side effects
- methionine dosage
- phenylalanine side effects
- phenylalanine dosage
- proline side effects
- proline dosage
- serine side effects
- serine dosage
- taurine side effects
- taurine dosage
- threonine side effects
- threonine dosage
- tryptophan side effects
- tryptophan dosage
- tyrosine side effects
- tyrosine dosage
- valine side effects
- valine dosage
